Literature DB >> 21043350

Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes.

R P Agrawal1, R Sharma, D Garg, R Pokharna, D K Kochar, R P Kothari.   

Abstract

A cross-sectional case-control study was conducted in 80 diabetic patients, to evaluate the incidence of gastropathy by endoscopy in type 2 diabetes mellitus. An association between Helicobacter pylori infection and non-gastrointestinal complication of diabetes mellitus was also looked into. Gastric biopsies were subjected to rapid urease test for demonstration of Helicobacter pylori. The fasting blood glucose levels among Helicobacter pylori positive diabetes were 175 +/- 36.5 mg %, and in Helicobacter pylori negative diabetics were 138 +/- 39.4 mg %. The prevalence of endoscopically detectable gastro-intestinal complications were higher in Helicobacter pylori infected diabetics (odd's ratio 4:2; p < 0.05). The total prevalence of Helicobacter pylori positive in diabetics by rapid urease test was statistically significant (p < 0.05). Coronary heart disease was more prevalent in diabetics with Helicobacter pylori infection than those without Helicobacter pylori (57%). The prevalence of H. pylori positivity in other complications such as peripheral vascular diseases, cerebrovascular diseases was not significant. The association between nephropathy, retinopathy and neuropathy with Helicobacter pylori, was also observed and the strong association was seen in diabetic retinopathy (p < 0.001), diabetic neuropathy (p < 0.01) and nephropathy (p < 0.001).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21043350

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  8 in total

Review 1.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Prevalence of Helicobacter pylori Infection among Type 2 Diabetes Mellitus.

Authors:  Abdulbari Bener; Ahmet Faruk Ağan; Abdulla O A A Al-Hamaq; Cem Cahit Barisik; Mustafa Öztürk; Abdulkadir Ömer
Journal:  Adv Biomed Res       Date:  2020-07-27

Review 3.  Is Helicobacter pylori infection associated with glycemic control in diabetics?

Authors:  Yi-Ning Dai; Wei-Lai Yu; Hua-Tuo Zhu; Jie-Xia Ding; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

4.  Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics?

Authors:  Jamshid Vafaeimanesh; Mahmoud Parham; Mohammad Bagherzadeh
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

5.  Serum adiponectin level in diabetic patients with and without Helicobacter pylori infection: is there any difference?

Authors:  Jamshid Vafaeimanesh; Akram Heidari; Marzieh Effatpanah; Mahmoud Parham
Journal:  ScientificWorldJournal       Date:  2014-01-09

Review 6.  Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis.

Authors:  Jun-Zhen Li; Jie-Yao Li; Ting-Feng Wu; Ji-Hao Xu; Can-Ze Huang; Di Cheng; Qi-Kui Chen; Tao Yu
Journal:  Gastroenterol Res Pract       Date:  2017-08-13       Impact factor: 2.260

Review 7.  Role of Helicobacter pylori infection in the manifestation of old age-related diseases.

Authors:  Abolfazl Zendehdel; Maryam Roham
Journal:  Mol Genet Genomic Med       Date:  2020-02-17       Impact factor: 2.183

8.  Clinical therapeutic effects of eradication of Helicobacter pylori in treating patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis.

Authors:  Zhi-Guo Shi; Li-Hui Chen
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.